Search results for "Anti-infective agents"

showing 10 items of 197 documents

Biophysical Models as an Approach To Study Passive Absorption in Drug Development: 6-Fluoroquinolones

1995

A preliminary study attempting to assess and explain the intestinal absorption of a series of antibacterial 7-piperazinyl-6-fluoroquinolones is presented. The synthesis, n-octanol partition coefficients, intrinsic rat gut in situ absorption rate constants, and in vitro antibacterial activity data found for these homologous compounds are described. A fluorimetric, reverse-phase HPLC method was performed for the quantification of the quinolones in absorption and partition samples. Equations based on two classic biophysical absorption models are given for predicting the intrinsic absorption features of the series according to the partition data or merely single structural parameters. In situ a…

MaleIn situChemical PhenomenaBiophysicsAnalytical chemistryAdministration OralPharmaceutical ScienceModels BiologicalBiophysical PhenomenaIntestinal absorptionBiopharmaceuticsAnti-Infective AgentsPharmacokineticsIn vivoComputational chemistryAnimalsPartition (number theory)Rats WistarAbsorption (electromagnetic radiation)Chromatography High Pressure LiquidBacteriaChemistry PhysicalChemistryLipidsRatsMolecular WeightPartition coefficientIntestinal AbsorptionInjections IntravenousAntibacterial activityFluoroquinolonesJournal of Pharmaceutical Sciences
researchProduct

Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of he…

2015

Background: To evaluate, in an initial way, the effectiveness of bioadhesive chlorhexidine gel 0.2% versus placebo as a preventive and therapeutic intervention of oral mucositis induced by radiation therapy and chemotherapy in patients diagnosed with head and neck cancer treated with chemoradiotherapy. Material and Methods: In this pilot study, 7 patients (range of age: 18- 65), having histological documented diagnosis of squamous carcinoma on the head and neck region in stage III and IV, and receiving combined radiation treatment and chemotherapy (cisplatin 100 mg/m2 IV on days 1, 22, and 43 of irradiation) were studied. Simultaneously, a topical application was performed with bioadhesive …

MaleMucositismedicine.medical_specialtymedicine.medical_treatmentOdontologíaBiocompatible MaterialsPilot ProjectsPlaceboHead and neck cancer.Double-Blind MethodmedicineMucositisHumansProspective StudiesGeneral DentistryChemotherapyStomatitisbusiness.industryResearchHead and neck cancerChlorhexidineChlorhexidineChemoradiotherapyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgerySquamous carcinomaRadiation therapyOtorhinolaryngologyHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryFemaleTissue AdhesivesOral SurgerybusinessGelsChemoradiotherapymedicine.drugMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study.

2013

Background Current recommendations for empirical antimicrobial therapy in spontaneous bacterial peritonitis (SBP) are based on quite old trials. Since microbial epidemiology and the management of patients have changed, whether these recommendations are still appropriate must be confirmed. Methods An observational study that exhaustively collected the clinical and biological data associated with positive ascitic fluid cultures was conducted in four French university hospitals in 2010–2011. Results Two hundred and sixty-eight documented positive cultures were observed in 190 cirrhotic patients (median age 61.5 years, 58.5% Child score C). Of these, 57 were classified as confirmed SBP and 140 …

MalePathologymedicine.medical_specialtyAntibiotic susceptibilitymedicine.drug_classEpidemiologyAntibioticsCephalosporinResistanceContext (language use)Microbial Sensitivity TestsPeritonitisAmoxicillin-Potassium Clavulanate CombinationAntibiotic resistanceMedical microbiologySpontaneous bacterial peritonitisAnti-Infective Agents[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyEpidemiologyDrug Resistance BacterialmedicineEscherichia coliSpontaneous bacterial peritonitisAscitic FluidHumans[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyAgedCross Infection[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryBacterial InfectionsMiddle AgedAntimicrobialmedicine.disease3. Good healthAnti-Bacterial AgentsTreatment Outcome[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesBacterascitesFemalebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyResearch Article
researchProduct

Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study

2003

Abstract Background. Rabeprazole is a new proton pump inhibitor, which has been reported to induce a faster acid suppression than other drugs of the same category. This might be useful to reduce the duration of anti-Helicobacter therapies. Aims. The aim of this study was to assess whether there is the possibility of shortening a rabeprazole-based triple therapy from 7 to 4 days without compromising its efficacy in the eradication of Helicobacter pylori infection. Patients. A total of 128 consecutive dyspeptic patients with H. pylori infection were recruited for this controlled, randomized, open and parallel-group trial comparing the efficacy of two durations of the same rabeprazole-based tr…

MalePeptic Ulcermedicine.medical_specialtymedicine.drug_classUrea breath testRabeprazoleProton-pump inhibitorPilot ProjectsGastroenterology2-PyridinylmethylsulfinylbenzimidazolesDrug Administration ScheduleHelicobacter InfectionsAnti-Infective AgentsClarithromycinMetronidazoleClarithromycinInternal medicinemedicineHumansProspective StudiesDyspepsiaAdverse effectHelicobacter pyloriHepatologybiologymedicine.diagnostic_testbusiness.industryGastroenterologyProton Pump InhibitorsMiddle AgedHelicobacter pyloriAnti-Ulcer Agentsbiology.organism_classificationAnti-Bacterial AgentsMetronidazoleRegimenTreatment OutcomeRabeprazoleBenzimidazolesDrug Therapy CombinationFemalebusinessOmeprazolemedicine.drug
researchProduct

Dystrophic epidermolysis bullosa: oral findings and problems.

2006

Dystrophic epidermolysis bullosa (DEB) is one of the three major types of epidermolysis bullosa (EB), an inherited cutaneous disease with blister formation following minor trauma. A subtype of DEB is recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type (RDEB-HS), where marked scarring leads to deformities of extremities. In RDEB-HS the mucous membranes may also be involved and form adhesions with ankyloglossia and microstomia. Oral hygiene is difficult. A 7-year-old boy with RDEB-HS was brought to the Johannes Gutenberg University dental clinic with dental pain. He had multiple carious lesions, poor oral hygiene and gingivitis. Because he was noncompliant and had microstomia, …

MalePit and Fissure SealantsToothbrushingmedicine.medical_specialtyMouthwashesDiseaseDental CariesOral hygieneGingivitismedicineHumansChildDental Restoration PermanentGeneral Dentistrybusiness.industryMicrostomiaDental Care for DisabledChlorhexidineChlorhexidineEpidermolysis bullosa dystrophicamedicine.diseaseDental Care for DisabledDermatologyEpidermolysis Bullosa Dystrophicastomatognathic diseasesTooth ExtractionAnti-Infective Agents LocalEpidermolysis bullosamedicine.symptombusinessmedicine.drugFollow-Up StudiesSpecial care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
researchProduct

The ocular penetration of oral sparfloxacin in humans

1994

The penetration of sparfloxacin into the aqueous humor after oral administration was studied in 28 patients undergoing cataract surgery. Each patient received a single, oral dose of 400 mg of sparfloxacin. In eight other patients scheduled to undergo vitreal surgery, multiple daily oral doses were administered for a total amount of 1,000 mg. The aqueous levels were (mean +/- SEM) 0.127 +/- 0.036 microgram/ml to 0.404 +/- 0.159 microgram/ml from two to 24 hours after ingestion. In the vitreous, the mean drug level was 0.840 microgram/ml (range, 0.480 to 2.060 microgram/ml), from 4.3 to 8.0 hours after the most recent oral dose. Blood samples obtained at the same time as vitreous and aqueous …

Malemedicine.drug_classmedicine.medical_treatment[SDV]Life Sciences [q-bio]AntibioticsAdministration OralCataract ExtractionMicrobial Sensitivity TestsQuinolonesAqueous HumorPharmacokineticsAnti-Infective AgentsOral administrationVitrectomyMedicineIngestionHumansChromatography High Pressure LiquidAntibacterial agentAgedAged 80 and overChemotherapybusiness.industryCataract surgeryMiddle Agedeye diseases[SDV] Life Sciences [q-bio]Vitreous BodyOphthalmologySparfloxacinAnesthesiaFemalesense organsbusinessmedicine.drugFluoroquinolones
researchProduct

The Pharmacokinetics of Metronidazole and Gentamicin in a Single Preoperative Dose as Antibiotic Prophylaxis in Colorectal Surgery

2008

Objective: To describe, in patients undergoing colorectal surgery (CRS), the pharmacokinetics of a single, prophylactic preoperative dose of 1500 mg of metronidazole plus 240 mg gentamicin and measure its efficacy in accordance with the accepted pharmacodynamic and microbiological parameters. Method: Thirty-six patients undergoing CRS agreed to participate in the study. Three blood samples were taken from each. Cmax 15 minutes after finishing the infusion of the mixture, CfinIQ on finishing the surgery, and Cmin between 12 and 24 hours post-administration. The concentrations of metronidazole and gentamicin in each simple were measured and the pharmacokinetic parameters were estimated (dV-di…

Malemedicine.medical_specialtyCmaxGastroenterologyColonic DiseasesCminAnti-Infective AgentsPharmacokineticsMetronidazoleInternal medicinePreoperative CaremedicineHumansProspective StudiesAntibiotic prophylaxisbusiness.industryAntibiotic ProphylaxisMiddle AgedAntimicrobialMetronidazoleRectal DiseasesAnesthesiaPharmacodynamicsFemaleGentamicinGentamicinsbusinessmedicine.drugFarmacia Hospitalaria (English Edition)
researchProduct

The treatment of venous leg ulcers: a new therapeutic use of iloprost

2007

Background: We conducted a study using an intravenous (i.v.) infusion of iloprost in the treatment of venous ulcers to verify whether the association of i.v. iloprost + local therapy + elastic compression has a favorable effect when compared with traditional treatment with local therapy and elastic compression. Study Design: We evaluated the effects of iloprost in 98 consecutive patients with noncomplicated venous ulcers of lower limbs subdivided into 2 groups: the first group (48 patients) received iloprost in saline solution for 3 weeks and the second group (50 patients) received a venous infusion of a saline solution. The patients were examined at baseline time 0 (first visit) and then a…

Malemedicine.medical_specialtyElastic compressionmedicine.medical_treatmentIschemiaPlacebo groupDrug Administration Schedulelaw.inventionRandomized controlled triallawmedicineHumansSingle-Blind MethodIloprostInfusions IntravenousVeinSalineDose-Response Relationship Drugbusiness.industryvenous ulcersiloprostLeg UlcerSignificant differenceMiddle Agedmedicine.diseaseCombined Modality TherapySurgeryTreatment Outcomemedicine.anatomical_structureDebridementAnesthesiaAnti-Infective Agents LocalFemaleSurgeryVENOUS LEG ULCERS ILOPROSTbusinessPlatelet Aggregation InhibitorsStockings CompressionIloprostmedicine.drug
researchProduct

Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse.

2009

Objective: To assess the effects of an antiseptic, non-alcohol based mouth-rinse containing chlorhexidine and cetylpyridinium chloride, in preventing the oral complications associated to radiation therapy in head-and-neck cancer patients. Study design: This was a parallel, double blind, prospective, randomized clinical trial. Cancer patients were randomly assigned to one of the two treatments (test mouth-rinse or a placebo). Three visits were scheduled (baseline, 14 and 28 days). Different outcome variables were evaluated: mucositis, plaque and gingival indices, stimulated saliva and salivary pH. Results: 70 patients were screened and 36 were included. The presence and the degree of mucosit…

Malemedicine.medical_specialtySalivamedicine.drug_classMouthwashesDentistryCetylpyridiniumPlaceboCetylpyridinium chloridelaw.inventionchemistry.chemical_compoundAntisepticRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineMucositisHumansProspective StudiesRadiation InjuriesGeneral DentistryStomatitisbusiness.industryChlorhexidineChlorhexidineCancerMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOtorhinolaryngologychemistryHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASAnti-Infective Agents LocalSurgeryFemalebusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Carvacrol affects interfacial, structural and transfer properties of chitosan coatings applied onto polyethylene

2012

Different chitosan coating solutions were tested with the aim of investigating their adhesion and wettability onto polyethylene film to improve packaging performance and provide antimicrobial properties. Surface wetting kinetics was monitored by contact angle measurements. Addition of ethanol and carvacrol improved wettability and adhesion of the thin chitosan layer. Structure, water vapour, O2, CO2 and air permeabilities of self supported chitosan films and coated polyethylene were determined. The formation of a thin chitosan layer on polyethylene improved gas barrier properties decreasing the Permeability Coefficient for oxygen and carbon dioxide ( [Formula: see text] , [Formula: see text…

Materials sciencePolymers and PlasticsSurface Propertiesmacromolecular substancesengineering.materialPermeabilityChitosanContact anglechemistry.chemical_compoundAnti-Infective AgentsCoatingMaterials Chemistrybio-based polymer; coating; chitosan; wettability; surface energy; permeabilityComposite materialChitosanOrganic Chemistrytechnology industry and agricultureAdhesionCarbon DioxidePolyethyleneSurface energyOxygencarbohydrates (lipids)chemistryPolyethyleneMonoterpenesWettabilityengineeringCymenesWettingLayer (electronics)
researchProduct